Antiretroviral treatment (ART) can impact results obtained with assays used for cross-sectional HIV incidence estimation, causing inaccurate HIV incidence estimates. We evaluated the relationship between the timing of ART initiation and the performance of two HIV incidence assays (the Sedia LAg-Avidity assay and the Johns Hopkins modified BioRad-Avidity assay).
We analyzed 302 samples from 55 individuals from, Thailand, Kenya, and Uganda (RV 217, Early Capture HIV Cohort Study). The average number of samples per participant was 5.5 (range 4-7); samples were collected 0.15 to 4.20 years after infection. Participants were assigned to one of three groups: never received ART (N=34); started ART 1-3 years after infection (N=12); started ART <1 year after infection (N=9). Samples were tested using the two assays. LAg-Avidity results from this cohort were compared to results from 17 participants in the Johns Hopkins HIV Cohort who started ART ~10 years after infection. All subjects on ART were virally suppressed.
The rate of change for LAg- Avidity values in the first year after infection was 2.77 normalized optical density units (OD-n)/year for those who never started ART, and 2.65 OD-n/year for those who started ART 1-3 years after infection. Most participants (7/9) who started ART ≤1 year after infection, did not exhibit the usual increase in LAg-Avidity values early in infection. The mean decrease in LAg-Avidity values after ART initiation was 0.94 OD-n/year for those who started ART 1-3 years after infection, compared to 0.22 OD-n/year for those who started ART ~10 years after infection (p=0.003). There was no statistically significant difference in BioRad-Avidity values among those who did and did not receive ART (p=0.069).
Individuals who started ART 1-3 years after infection had a significantly faster decline in LAg-Avidity values than those who started ART ~10 years after infection. BioRad-Avidity values were not impacted by ART and use of this assay may provide more accurate incidence estimates in populations where ART use is unknown or inconsistent. Individuals who started ART <1 year after infection, (especially those that started ART ≤3 months after infection) had persistently low LAg-Avidity values; this could lead to overestimation of HIV incidence estimates.